Sales Growth YoY (Last Twelve Months): Lipocine Corporation (LPCN)

Graphic logo of Lipocine Inc. (LPCN)

Lipocine Inc. is implementing closed-loop water cycles to minimize environmental impact. The current year-over-year sales trend over 12 months on GURU.Markets illustrates the market response, where the value of -13.60 serves as the baseline indicator. Experienced management at Lipocine Inc. (LPCN) is mitigating FDA risks, while the development strategy relies on internal R&D and targeted licensing without mergers.

Sales Growth YoY (Last Twelve Months): Lipocine Corp (LPCN) for 02/11/2024 - 11/18/2026

Summary analytical data breakdowns for Lipocine (LPCN)

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Summary company analytics:LPCN Lipocine Corporation
Mass-produced product of lipocine.com

The scale of operations at Lipocine Inc. (LPCN) reflects the annual sales revenue growth rate (rolling period). This indicator measures the percentage change in revenue over the last twelve months relative to the same window from the previous year. The dynamic calculation eliminates quarterly gaps, demonstrating the actual speed of business expansion. For a drug delivery systems developer, such a metric confirms the commercialization of its patent portfolio. Investors use this trend to assess the market adoption of new therapeutic methods.

Competitors of Lipocine Inc. (LPCN)

Ascendis (ASND) - Trailing Twelve Months Revenue Growth|MDGL - Sales Growth YoY (Last Twelve Months)|CORT: Sales Growth YoY (Last Twelve Months)|RYTM: Sales Growth YoY (TTM)|AKRO - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Metsera Therapeutics|MoonLake Corp (MLTX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) crinetics.com (CRNX)|Revenue Growth YoY (Last 12 Months) newamsterdampharma.com NAMS|Sales Growth YoY (Last Twelve Months) Soleno Therapeutics Inc SLNO|Sales Growth YoY (TTM) Amicus Therapeutics Inc FOLD|89bio Corp - Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Agios Pharmaceuticals Inc (AGIO)|Structure Therapeutics (GPCR) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) MiMedx Group, Inc.|Sales Growth YoY (Last Twelve Months) Rezolute Bio|Lexicon Pharmaceuticals, Inc. (LXRX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) MBX|Revenue Growth YoY (Last 12 Months) Altimmune, Inc. ALT|Sales Growth YoY (TTM) AARD (Aardvark Pharma)|Sagimet Biosciences Inc. (SGMT) - Trailing Twelve Months Revenue Growth|BIOA: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) BMEA (Biomea Fusion)|QNCX (quincetx.com) - Revenue Growth YoY (Last 12 Months)|Fractyl - Revenue Dynamics YoY (Last Twelve Months)|VTVT (vTv Therapeutics Inc) - Sales Growth YoY (TTM)|Agape ATP - Trailing Twelve Months Sales Growth|Revenue Growth YoY (Last 12 Months) PLUR (Pluri Inc)|Annual Revenue Growth (Last Twelve Months) Synlogic Inc.|Sales Growth YoY (Last Twelve Months) Matinas BioPharma Holdings MTNB|Annual Revenue Growth (Last Twelve Months) Spruce Biosciences (SPRB)|GLTO: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth CTCX|LUMO (Lumos Pharma) - Revenue Growth YoY (Last 12 Months)|Sales Growth YoY (Last 12 Months) ONVO|RDUS (Radius Pharmaceuticals) - Sales Growth YoY (TTM)